29e7037487ffc5cc0a3a4605b5b29151 302244.pdf e989bb979ca8678fedc50f6258fc8b08d9cb26f7 302244.pdf 321083f58a12c9ec372c8f30b41917ff4a54ef50218a8ee8596deee5d60841c2 302244.pdf Title: Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer Subject: British Journal of Cancer 110, 2201 (2014). doi:10.1038/bjc.2014.189 Author: A G de Liaño Creator: Arbortext Advanced Print Publisher 9.0.226/W Producer: Acrobat Distiller 8.1.0 (Windows) CreationDate: Tue Apr 15 15:05:14 2014 CEST ModDate: Sat Apr 19 09:39:51 2014 CEST Custom Metadata: no Metadata Stream: yes Tagged: no UserProperties: no Suspects: no Form: AcroForm JavaScript: no Pages: 8 Encrypted: no Page size: 595.276 x 793.701 pts Page rot: 0 File size: 764014 bytes Optimized: yes PDF version: 1.6 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- HLBHGO+AdvOT3b9b4d35 Type 1C WinAnsi yes yes no 245 0 HLBGMH+AdvOTa851a675.B Type 1C WinAnsi yes yes no 209 0 HLBGMI+AdvOTb0d2661a Type 1C WinAnsi yes yes no 210 0 HLBGMJ+AdvOTf1c06d06.I Type 1C WinAnsi yes yes no 211 0 HLBGMK+AdvOTdadbfad7.B Type 1C WinAnsi yes yes no 212 0 HLBGML+AdvOT0906c96e Type 1C WinAnsi yes yes no 213 0 HLBGMM+AdvEls-ent4 Type 1C WinAnsi yes yes no 219 0 HLBGMN+AdvP4C4E74 Type 1C Custom yes yes yes 220 0 HLBGNO+AdvOT1ef757c0 Type 1C Custom yes yes yes 227 0 HLBGOO+AdvOT7d6df7ab.I Type 1C Custom yes yes yes 233 0 HLBGOP+AdvTA42 Type 1C Custom yes yes yes 240 0 HLBHAA+AdvOTfe809cc4 Type 1C WinAnsi yes yes no 241 0 HLBHKO+AdvOTb65e897d.B Type 1C Custom yes yes yes 89 0 HLBHLO+AdvEls-ent5 Type 1C WinAnsi yes yes no 91 0 HLBHMP+AdvPi1 Type 1C WinAnsi yes yes no 84 0 HLBHOP+AdvOT1916b968.BI Type 1C WinAnsi yes yes no 82 0 HLBHPA+AdvItcSymbol-M Type 1C WinAnsi yes yes no 87 0 HLBJHI+Helvetica Type 1C WinAnsi yes yes no 100 0 HLCAAB+Helvetica-Oblique Type 1C WinAnsi yes yes no 103 0 HLCFFB+MathematicalPi-One Type 1C Custom yes yes no 104 0 Jhove (Rel. 1.28.0, 2023-05-18) Date: 2024-10-18 02:54:19 CEST RepresentationInformation: 302244.pdf ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16) LastModified: 2024-10-17 17:30:04 CEST Size: 764014 Format: PDF Version: 1.6 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf Profile: Linearized PDF PDFMetadata: Objects: 266 FreeObjects: 1 IncrementalUpdates: 1 DocumentCatalog: PageLayout: SinglePage PageMode: UseNone Outlines: Item: Title: title_link Destination: title_link Children: Item: Title: Patients and methods Destination: A1 Children: Item: Title: Study population Destination: B1 Item: Title: Statistical analysis Destination: B2 Item: Title: Results Destination: A2 Children: Item: Title: Patient population Destination: B3 Item: Title: Table 1 Destination: tab_bktbltbl1 Children: Item: Title: Efficacy and survival analyses Destination: B4 Item: Title: Response to SHT and post-progression survival Destination: B5 Item: Title: Discussion Destination: A3 Item: Title: Figure™1Distribution of serum androgen levels at baseline Destination: fig_bkfigfig1 Item: Title: Table 2 Destination: tab_bktbltbl2 Item: Title: Figure™2Disease-free survival (A) and overall survival (B) according to testosterone baseline levels Destination: fig_bkfigfig2 Item: Title: Figure™3Overall survival according to the presence of anaemia (A) or age (B) at baseline Destination: fig_bkfigfig3 Item: Title: A4 Destination: A4 Item: Title: ACKNOWLEDGEMENTS Destination: M1 Item: Title: A5 Destination: A5 Item: Title: Figure™4Overall survival according to prognostic groups Destination: fig_bkfigfig4 Item: Title: Figure™5Time from progression to first-line therapy to death Destination: fig_bkfigfig5 Info: Title: Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer Author: A G de Liaño Subject: British Journal of Cancer 110, 2201 (2014). doi:10.1038/bjc.2014.189 Creator: Arbortext Advanced Print Publisher 9.0.226/W Producer: Acrobat Distiller 8.1.0 (Windows) CreationDate: Tue Apr 15 15:05:14 CEST 2014 ModDate: Sat Apr 19 10:09:51 CEST 2014 ID: 0xf14caa769b0699bf0acaebbd29fb6e01, 0x7fdec427ee8b6445a3fe75d71c481a4a Filters: FilterPipeline: FlateDecode FilterPipeline: DCTDecode Images: Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1482 ImageHeight: 1017 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 2430 ImageHeight: 1402 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 2430 ImageHeight: 1399 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 2390 ImageHeight: 1407 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 2352 ImageHeight: 1404 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 2422 ImageHeight: 1396 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 2402 ImageHeight: 1385 BitsPerSample: 8 BitsPerSampleUnit: integer Fonts: Type1: Font: BaseFont: HLBGNO+AdvOT1ef757c0 FontSubset: true FirstChar: 31 LastChar: 180 FontDescriptor: FontName: HLBGNO+AdvOT1ef757c0 Flags: Serif, Symbolic FontBBox: -135, -250, 1010, 854 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: HLBJHI+Helvetica FontSubset: true FirstChar: 32 LastChar: 150 FontDescriptor: FontName: HLBJHI+Helvetica Flags: Nonsymbolic FontBBox: -166, -225, 1000, 931 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLCAAB+Helvetica-Oblique FontSubset: true FirstChar: 32 LastChar: 80 FontDescriptor: FontName: HLCAAB+Helvetica-Oblique Flags: Nonsymbolic, Italic FontBBox: -170, -225, 1116, 931 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLCFFB+MathematicalPi-One FontSubset: true FirstChar: 2 LastChar: 2 FontDescriptor: FontName: HLCFFB+MathematicalPi-One Flags: Symbolic FontBBox: -30, -210, 1000, 779 FontFile3: true EncodingDictionary: Differences: true Font: BaseFont: HLBGOO+AdvOT7d6df7ab.I FontSubset: true FirstChar: 46 LastChar: 118 FontDescriptor: FontName: HLBGOO+AdvOT7d6df7ab.I Flags: Serif, Symbolic FontBBox: -156, -250, 1000, 854 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: HLBGOP+AdvTA42 FontSubset: true FirstChar: 38 LastChar: 38 FontDescriptor: FontName: HLBGOP+AdvTA42 Flags: Serif, Symbolic FontBBox: -72, -145, 875, 718 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: HLBHAA+AdvOTfe809cc4 FontSubset: true FirstChar: 40 LastChar: 124 FontDescriptor: FontName: HLBHAA+AdvOTfe809cc4 Flags: Nonsymbolic FontBBox: -166, -281, 1000, 916 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBGMH+AdvOTa851a675.B FontSubset: true FirstChar: 45 LastChar: 121 FontDescriptor: FontName: HLBGMH+AdvOTa851a675.B Flags: Nonsymbolic FontBBox: -156, -250, 1125, 947 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBGMI+AdvOTb0d2661a FontSubset: true FirstChar: 42 LastChar: 152 FontDescriptor: FontName: HLBGMI+AdvOTb0d2661a Flags: Nonsymbolic FontBBox: -156, -250, 1000, 927 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBHOP+AdvOT1916b968.BI FontSubset: true FirstChar: 80 LastChar: 110 FontDescriptor: FontName: HLBHOP+AdvOT1916b968.BI Flags: Nonsymbolic FontBBox: -156, -270, 1187, 937 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBGMJ+AdvOTf1c06d06.I FontSubset: true FirstChar: 44 LastChar: 121 FontDescriptor: FontName: HLBGMJ+AdvOTf1c06d06.I Flags: Nonsymbolic FontBBox: -166, -270, 1031, 927 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBGMK+AdvOTdadbfad7.B FontSubset: true FirstChar: 37 LastChar: 121 FontDescriptor: FontName: HLBGMK+AdvOTdadbfad7.B Flags: Nonsymbolic FontBBox: -156, -250, 1156, 937 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBHMP+AdvPi1 FontSubset: true FirstChar: 52 LastChar: 52 FontDescriptor: FontName: HLBHMP+AdvPi1 Flags: Serif, Nonsymbolic FontBBox: 13, -323, 958, 824 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBHGO+AdvOT3b9b4d35 FontSubset: true FirstChar: 40 LastChar: 121 FontDescriptor: FontName: HLBHGO+AdvOT3b9b4d35 Flags: Nonsymbolic FontBBox: -156, -281, 1031, 916 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBGML+AdvOT0906c96e FontSubset: true FirstChar: 37 LastChar: 150 FontDescriptor: FontName: HLBGML+AdvOT0906c96e Flags: Nonsymbolic FontBBox: -166, -250, 1000, 927 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBHPA+AdvItcSymbol-M FontSubset: true FirstChar: 177 LastChar: 177 FontDescriptor: FontName: HLBHPA+AdvItcSymbol-M Flags: Nonsymbolic FontBBox: -62, -229, 1208, 833 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBHKO+AdvOTb65e897d.B FontSubset: true FirstChar: 45 LastChar: 121 FontDescriptor: FontName: HLBHKO+AdvOTb65e897d.B Flags: Serif, Symbolic FontBBox: -125, -250, 1052, 854 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: HLBGMM+AdvEls-ent4 FontSubset: true FirstChar: 111 LastChar: 112 FontDescriptor: FontName: HLBGMM+AdvEls-ent4 Flags: Nonsymbolic FontBBox: 0, -343, 1166, 1218 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBHLO+AdvEls-ent5 FontSubset: true FirstChar: 88 LastChar: 88 FontDescriptor: FontName: HLBHLO+AdvEls-ent5 Flags: Serif, Nonsymbolic FontBBox: 9, -343, 1166, 791 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HLBGMN+AdvP4C4E74 FontSubset: true FirstChar: 2 LastChar: 254 FontDescriptor: FontName: HLBGMN+AdvP4C4E74 Flags: Symbolic FontBBox: -20, -958, 1114, 770 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true XMP: application/pdf doi:10.1038/bjc.2014.189 A G de Liaño O Reig B Mellado C Martin E U Rull J P Maroto British Journal of Cancer 110, 2201 (2014). doi:10.1038/bjc.2014.189 Nature Publishing Group © 2014 Nature Publishing Group Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer Acrobat Distiller 8.1.0 (Windows) © 2014 Cancer Research UK 10.1038/bjc.2014.189 1532-1827 2208 0007-0920 9 British Journal of Cancer 2201 110 2014-04-10 permissions@nature.com http://dx.doi.org/10.1038/bjc.2014.189 2014-04-15T13:05:14Z Arbortext Advanced Print Publisher 9.0.226/W British Journal of Cancer 110, 2201 (2014). doi:10.1038/bjc.2014.189 2014-04-19T13:09:51+05:30 2014-04-19T13:09:51+05:30 doi:10.1038/bjc.2014.189 True uuid:d471b043-c1a9-4207-98b4-ca92cb29a9f4 uuid:9fb1acbd-3476-4fc4-9245-967dd36279ff Pages: Page: Label: 1 Annotations: Annotation: Subtype: Link Rect: 220, 112, 288, 122 Destination: 73 Annotation: Subtype: Link Rect: 111, 102, 189, 111 Destination: 73 Annotation: Subtype: Link Rect: 306, 186, 376, 195 Destination: 73 Annotation: Subtype: Link Rect: 382, 186, 452, 195 Destination: 73 Annotation: Subtype: Link Rect: 345, 165, 419, 174 Destination: 73 Annotation: Subtype: Link Rect: 363, 133, 440, 143 Destination: 73 Annotation: Subtype: Link Rect: 449, 133, 533, 143 Destination: 73 Annotation: Subtype: Link Rect: 414, 123, 498, 132 Destination: 73 Annotation: Subtype: Link Rect: 189, 74, 262, 82 Annotation: Subtype: Link Rect: 43, 20, 118, 29 Thumb: true Page: Label: 2 Annotations: Annotation: Subtype: Link Rect: 140, 703, 215, 712 Destination: 73 Annotation: Subtype: Link Rect: 227, 692, 291, 702 Destination: 73 Annotation: Subtype: Link Rect: 43, 682, 61, 691 Destination: 73 Annotation: Subtype: Link Rect: 250, 345, 291, 354 Destination: 73 Annotation: Subtype: Link Rect: 43, 334, 90, 344 Destination: 73 Annotation: Subtype: Link Rect: 118, 313, 181, 323 Destination: 73 Annotation: Subtype: Link Rect: 351, 433, 428, 442 Destination: 73 Annotation: Subtype: Link Rect: 499, 334, 528, 344 Destination: 1 Annotation: Subtype: Link Rect: 372, 20, 446, 29 Thumb: true Page: Label: 3 Annotations: Annotation: Subtype: Link Rect: 75, 598, 107, 608 Destination: 15 Annotation: Subtype: Link Rect: 164, 556, 192, 566 Destination: 29 Annotation: Subtype: Link Rect: 184, 389, 257, 399 Destination: 43 Annotation: Subtype: Link Rect: 218, 368, 254, 378 Destination: 51 Annotation: Subtype: Link Rect: 127, 347, 162, 357 Destination: 51 Annotation: Subtype: Link Rect: 400, 431, 431, 440 Destination: 63 Annotation: Subtype: Link Rect: 483, 400, 514, 409 Destination: 63 Annotation: Subtype: Link Rect: 43, 20, 118, 29 Thumb: true Page: Label: 4 Annotations: Annotation: Subtype: Link Rect: 106, 191, 186, 200 Destination: 73 Annotation: Subtype: Link Rect: 66, 149, 142, 158 Destination: 63 Annotation: Subtype: Link Rect: 46, 128, 116, 137 Destination: 73 Annotation: Subtype: Link Rect: 122, 128, 220, 137 Destination: 73 Annotation: Subtype: Link Rect: 188, 97, 264, 106 Destination: 73 Annotation: Subtype: Link Rect: 140, 86, 222, 95 Destination: 73 Annotation: Subtype: Link Rect: 171, 55, 236, 64 Destination: 73 Annotation: Subtype: Link Rect: 306, 212, 390, 221 Destination: 73 Annotation: Subtype: Link Rect: 351, 180, 438, 190 Destination: 73 Annotation: Subtype: Link Rect: 448, 180, 524, 190 Destination: 73 Annotation: Subtype: Link Rect: 372, 20, 446, 29 Thumb: true Page: Label: 5 Annotations: Annotation: Subtype: Link Rect: 43, 20, 118, 29 Thumb: true Page: Label: 6 Annotations: Annotation: Subtype: Link Rect: 193, 139, 273, 148 Destination: 63 Annotation: Subtype: Link Rect: 372, 20, 446, 29 Thumb: true Page: Label: 7 Annotations: Annotation: Subtype: Link Rect: 43, 20, 118, 29 Thumb: true Page: Label: 8 Annotations: Annotation: Subtype: Link Rect: 453, 593, 503, 601 Annotation: Subtype: Link Rect: 315, 583, 483, 591 Annotation: Subtype: Link Rect: 372, 20, 446, 29 Thumb: true Checksum: 8686c1ad Type: CRC32 Checksum: 29e7037487ffc5cc0a3a4605b5b29151 Type: MD5 Checksum: e989bb979ca8678fedc50f6258fc8b08d9cb26f7 Type: SHA-1 Checksum: 321083f58a12c9ec372c8f30b41917ff4a54ef50218a8ee8596deee5d60841c2 Type: SHA-256